清金化痰汤联合美罗培南治疗老年重症肺炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R563.1

基金项目:

河南省医学科技攻关计划项目(LHGJ20200572)


Clinical Study on Qingjin Huatan Decoction Combined with Meropenem for Severe Pneumonia in Senile Patients
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察清金化痰汤联合美罗培南治疗老年重症肺炎(SP) 的疗效。方法:选取2023年4月— 2024年2月鹤壁市人民医院收治的120例老年SP患者,按随机数字表法分为西药组及中药组各60例。西药组 给予美罗培南治疗,中药组给予清金化痰汤联合美罗培南治疗。比较2组临床疗效及不良反应发生率,比较 2组治疗前后肺功能指标[第1秒用力呼气容积(FEV1)、最大呼气峰值流速(PEF)、用力肺活量(FVC)、平 均最大呼气流量(MMEF)] 值、免疫功能(CD4+、CD8+、CD4+/CD8+)、血气指标[动脉氧分压(PaO2)、二 氧化碳分压(PaCO2)、血氧饱和度(SpO2)] 值、白细胞介素-8(IL-8)、白细胞介素-10(IL-10)、中性粒细 胞弹性蛋白酶(NE) 水平的变化。结果:西药组临床疗效总有效率为83.33%(50/60),中药组临床疗效总有 效率为96.67%(58/60),2组比较,差异有统计学意义(P<0.05)。治疗后,2组FEV1、PEF、FVC、MMEF指 标值均较治疗前升高(P<0.05),中药组FEV1、PEF、FVC、MMEF指标值均大于西药组(P<0.05)。治疗后, 2组CD4+、CD4+/CD8+水平均较治疗前升高(P<0.05),CD8+水平均较治疗前下降(P<0.05);中药组CD4+、 CD4+/CD8+水平均高于西药组(P<0.05),CD8+水平低于西药组(P<0.05)。治疗后,2组PaO2、SpO2指标值均 较治疗前升高(P<0.05),PaCO2 指标值均较治疗前下降(P<0.05);中药组PaO2、SpO2 指标值高于西药组 (P<0.05),PaCO2指标值低于西药组(P<0.05)。治疗后,2组IL-8、IL-10、NE水平均较治疗前下降(P< 0.05),中药组IL-8、IL-10、NE水平均低于西药组(P<0.05)。中药组不良反应发生率为8.62%(5/58),西药 组不良反应发生率为14.00%(7/50),2组比较,差异无统计学意义(P>0.05)。结论:清金化痰汤联合美罗培 南治疗老年SP疗效较好,能改善患者肺功能,提高免疫功能,抑制炎症反应,安全性高。

    Abstract:

    Abstract:Objective:To observe the curative effect of Qingjin Huatan Decoction combined with Meropenem on severe pneumonia(SP)in senile patients. Methods:A total of 120 senile SP patients treated at the People's Hospital of Hebi from April 2023 to February 2024 were selected and divided into the western medicine group and the Chinese medicine group according to the random number table method,with 60 cases in each group. The western medicine group was treated with Meropenem, and the Chinese medicine group was treated with Qingjin Huatan Decoction combined with Meropenem. Clinical effects and the incidence of adverse reactions were compared between the two groups. The changes in lung function indexes [forced expiratory volume in the first second(FEV1), peak expiratory flow(PEF), forced vital capacity(FVC),mean maximal expiratory flow(MMEF)],immune function(CD4+,CD8+,CD4+/CD8+), blood gas indicators [arterial oxygen partial pressure(PaO2), carbon dioxide partial pressure(PaCO2), oxygen saturation(SpO2)], and levels of interleukin-8(IL-8), interleukin-10(IL-10), and neutrophil elastase(NE) before and after treatment were compared between the two groups. Results:The total effective rate of clinical effect was 83.33%(50/60)in the western medicine group and 96.67%(58/60)in the Chinese medicine group,with significant difference between the two groups(P<0.05). After treatment,the values of FEV1,PEF,FVC and MMEF in the two groups were increased when compared with those before treatment(P<0.05), with higher values in the Chinese medicine group than in the western medicine group(P<0.05). After treatment,the levels of CD4+ and CD4+/CD8+ in the two groups were increased when compared with those before treatment(P<0.05)and CD8+ levels were decreased when compared with those before treatment(P<0.05); the levels of CD4+ and CD4+/CD8+ in the Chinese medicine group were higher than those in the western medicine group(P<0.05),and CD8+ level in the Chinese medicine group was lower than that in the western medicine group(P<0.05). After treatment,the values of PaO2 and SpO2 in the two groups were increased when compared with those before treatment and PaCO2 values in the two groups were decreased when compared with those before treatment(P<0.05); the values of PaO2 and SpO2 in the Chinese medicine group were higher than in those in the western medicine group and PaCO2 value was lower than that in the western medicine group(P<0.05). After treatment, the levels of IL-8, IL-10, and NE in the two groups were decreased when compared with those before treatment(P<0.05);the levels of IL-8,IL-10,and NE in the Chinese medicine group were lower than those the western medicine group(P<0.05). The incidence of adverse reactions was 8.62%(5/58)in the Chinese medicine group and 14.00%(7/50)in the western medicine group,with no significant difference between the two groups(P>0.05). Conclusion: Qingjin Huatan Decoction combined with Meropenem has a good curative effect in treating senile SP patients, which can improve lung function, enhance immune function, and inhibit inflammatory responses with high safety.

    参考文献
    相似文献
    引证文献
引用本文

孙学功,张胜,张永楠.清金化痰汤联合美罗培南治疗老年重症肺炎临床研究[J].新中医,2025,57(19):33-38

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-10-20
  • 出版日期:
文章二维码